Skip to content
Home/Companies/Biotech/Oria Bioscience

Oria Bioscience

Biotech·France·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Oria Bioscience?

Oria Bioscience is a French Biotech company, currently owned by Newfund Management since 2025.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Newfund Management
Investor
Newfund Management
Newfund HEKA · 2023 · VC

Key facts

HQFrance
SectorBiotech

More from Newfund HEKA

Other portfolio companies in the same fund.

AI Stroke
Active
HealthcareFrance· 2025
Diagnoly
Active
HealthTechFrance· 2025
DUX Healthcare
Active
HealthcareUS· 2025
Moovd
Active
HealthcareNetherlands· 2025
Olimpe Technlogy
Active
HealthcareFrance· 2025
One Zyme
Active
HealthcareUS· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Oria Bioscience?

Oria Bioscience is currently owned by Newfund Management, through Newfund HEKA, since 2025.

When did Newfund Management acquire Oria Bioscience?

Newfund Management acquired Oria Bioscience in 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue